11.8 C
London
Tuesday, September 27, 2022

Biotech startup OccuRx raises $16 million for kidney disease research

Must read

Boom In Jobs: Corporate India gets to work, IT sector leads the way

The pace of job creation is rising to 8.5% after losses during the pandemic.According to Jefferies, total employee expenses grew 13% year-over-year in FY22,...

Inside The Life of Troy Landry: His Bio, Career, Net Worth

Troy Landry, known as The King of Swamp, is the most famous alligator hunter in America. Landry, 62, is the centerpiece of History...

Doug Mastriano said in 2019, women who violate the proposed abortion ban should be charged with murder

sen. Doug Mastriano of the state, the Republican nominee for governor in Pennsylvania, said in 2019 that women should be charged with murder...

A new Instagram test removes the store tab from the home screen • londonbusinessblog.com

Meta is making it harder to find the Store tab on Instagram with its latest test. In the new test, the Store tab...
Shreya Christinahttps://londonbusinessblog.com
Shreya has been with londonbusinessblog.com for 3 years, writing copy for client websites, blog posts, EDMs and other mediums to engage readers and encourage action. By collaborating with clients, our SEO manager and the wider londonbusinessblog.com team, Shreya seeks to understand an audience before creating memorable, persuasive copy.

Biotech startup OccuRx has raised $16 million to fund phase clinical trials for its oral therapy to treat chronic kidney disease (CKD), a leading cause of death.

The round was jointly led by Brandon BioCatalyst and Uniseed and also includes a $1.5 million grant from the biomedical incubator CUREator.

The funding will be used for a CKD clinical program for the lead compound OCX-063, following successful results in a Phase I clinical trial.

Chronic kidney disease affects millions of people worldwide, often as a result of other long-term illnesses, such as diabetes or cardiovascular disease, leading to fibrosis and kidney failure. There are no current treatments for renal fibrosis.

OccuRx executive chair Professor Darren Kelly said it is an exciting time for the startup’s clinical development program for patients with CKD.

“Our goal is to develop an oral therapy for the treatment and prevention of fibrosis that often leads to disease progression and organ failure,” he said.

“We continue to expand and strengthen our team at OccuRx as we progress through our CKD trial and beyond.”

To do that, the biotech Dr. Gareth Lewis appointed Chief Commercial Officer and Dr. Michelle Bradney as Chief Operating Officer.

dr. Lewis said he was excited about the potential to develop a treatment platform for a spectrum of inflammatory and fibrotic diseases.

“We have a shared mission and close collaboration with Australian biotech company Certa Therapeutics to improve the lives of patients suffering from difficult-to-treat and often life-threatening chronic diseases,” he said.

“The impact this collaboration could have in addressing the global concern and unmet need for inflammation and fibrosis is enormous.”

dr. Bradney signs with over 25 years of clinical development and medical experience in Australia and internationally.

“OccuRx has made significant progress in translating and advancing its lead compound into the clinical development phase,” she said.

It is an exciting time to join the team as we now move forward with clinical trials on patients with CKD.”

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Boom In Jobs: Corporate India gets to work, IT sector leads the way

The pace of job creation is rising to 8.5% after losses during the pandemic.According to Jefferies, total employee expenses grew 13% year-over-year in FY22,...

Inside The Life of Troy Landry: His Bio, Career, Net Worth

Troy Landry, known as The King of Swamp, is the most famous alligator hunter in America. Landry, 62, is the centerpiece of History...

Doug Mastriano said in 2019, women who violate the proposed abortion ban should be charged with murder

sen. Doug Mastriano of the state, the Republican nominee for governor in Pennsylvania, said in 2019 that women should be charged with murder...

A new Instagram test removes the store tab from the home screen • londonbusinessblog.com

Meta is making it harder to find the Store tab on Instagram with its latest test. In the new test, the Store tab...

Is Silicon Valley Really Losing Its Crown? • londonbusinessblog.com

Where is the heart of the technology industry? The simple answer is "Silicon Valley," a term that now generally means the San Francisco-San Jose-Oakland area...